Transcriptional profiling to identify biomarkers of disease and drug response

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Mendrick DL, Daniels KK: Biomarkers of drug-induced adverse events. Expert Rev. Clin. Pharmacol.1,81–91 (2008).Crossref, Medline, CAS, Google Scholar
• 2  Marchionni L, Wilson RF, Wolff AC et al.: Systematic review: gene expression profiling assays in early-stage breast cancer. Ann. Intern. Med.148,358–369 (2008).Crossref, Medline, Google Scholar
• 3  Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA: The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J. Lab. Clin. Med.147,126–132 (2006).Crossref, Medline, CAS, Google Scholar
• 4  Powell EE, Kroon PA: Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J. Clin. Invest.93,2168–2174 (1994).Crossref, Medline, CAS, Google Scholar
• 5  Aggarwal D, Freake HC, Soliman GA, Dutta A, Fernandez ML: Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism. Lipids Health Dis.5,22 (2006).Crossref, Medline, Google Scholar
• 6  Guan JZ, Tamasawa N, Murakami H et al.: HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in Type 2 diabetic patients with hyperlipidemia. J. Atheroscler. Thromb.15,20–25 (2008).Crossref, Medline, Google Scholar
• 7  Mikael LG, Rozen R: Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-κB/iNOS. Cardiovasc. Res.80,151–158 (2008).Crossref, Medline, CAS, Google Scholar
• 8  Pham MX, Teuteberg JJ, Kfoury AG et al.: Gene-expression profiling for rejection surveillance after cardiac transplantation. N. Engl. J. Med.362(20),1890–1900 (2010).Crossref, Medline, CAS, Google Scholar
• 9  Burczynski ME, Dorner AJ: Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies. Pharmacogenomics7,187–202 (2006).▪▪ Excellent review of the earlier findings in the area of pharmacogenomics of the blood.Link, CAS, Google Scholar
• 10  Tang Y, Lu A, Aronow BJ, Sharp FR: Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann. Neurol.50,699–707 (2001).Crossref, Medline, CAS, Google Scholar
• 11  Tang Y, Nee AC, Lu A, Ran R, Sharp FR: Blood genomic expression profile for neuronal injury. J. Cereb. Blood Flow Metab.23,310–319 (2003).Crossref, Medline, CAS, Google Scholar
• 12  Du X, Tang Y, Xu H et al.: Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine and Tourette syndrome. Genomics87,693–703 (2006).Crossref, Medline, CAS, Google Scholar
• 13  Tang Y, Xu H, Du X et al.: Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab.26,1089–1102 (2006).Crossref, Medline, CAS, Google Scholar
• 14  Xu H, Tang Y, Liu DZ et al.: Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J. Cereb. Blood Flow Metab.28,1320–1328 (2008).Crossref, Medline, CAS, Google Scholar
• 15  Lovrecic L, Kastrin A, Kobal J, Pirtosek Z, Krainc D, Peterlin B: Gene expression changes in blood as a putative biomarker for Huntington’s disease. Mov. Disord.24,2277–2281 (2009).Crossref, Medline, Google Scholar
• 16  Wong B, Gilbert DL, Walker WL et al.: Gene expression in blood of subjects with Duchenne muscular dystrophy. Neurogenetics10,117–125 (2009).Crossref, Medline, CAS, Google Scholar
• 17  Borovecki F, Lovrecic L, Zhou J et al.: Genome-wide expression profiling of human blood reveals biomarkers for Huntington’s disease. Proc. Natl Acad. Sci. USA102,11023–11028 (2005).Crossref, Medline, CAS, Google Scholar
• 18  Runne H, Kuhn A, Wild EJ et al.: Analysis of potential transcriptomic biomarkers for Huntington’s disease in peripheral blood. Proc. Natl Acad. Sci. USA104,14424–14429 (2007).Crossref, Medline, CAS, Google Scholar
• 19  Scherzer CR, Eklund AC, Morse LJ et al.: Molecular markers of early Parkinson’s disease based on gene expression in blood. Proc. Natl Acad. Sci. USA104,955–960 (2007).Crossref, Medline, CAS, Google Scholar
• 20  Bowden NA, Weidenhofer J, Scott RJ et al.: Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr. Res.82,175–183 (2006).Crossref, Medline, Google Scholar
• 21  Takahashi M, Hayashi H, Watanabe Y et al.: Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr. Res.119,210–218 (2010).Crossref, Medline, Google Scholar
• 22  Tang Y, Glauser TA, Gilbert DL et al.: Valproic acid blood genomic expression patterns in children with epilepsy – a pilot study. Acta Neurol. Scand.109,159–168 (2004).Crossref, Medline, CAS, Google Scholar
• 23  Le Niculescu H, Kurian SM, Yehyawi N et al.: Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol. Psychiatry14(2),156–174 (2008).▪▪ Interesting approach to identifying translational biomarkers.Crossref, Medline, Google Scholar
• 24  Ogden CA, Rich ME, Schork NJ et al.: Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol. Psychiatry9,1007–1029 (2004).Crossref, Medline, CAS, Google Scholar
• 25  Kurian SM, Le-Niculescu H, Patel SD et al.: Identification of blood biomarkers for psychosis using convergent functional genomics. Mol. Psychiatry16(1),37–58 (2011).Crossref, Medline, CAS, Google Scholar
• 26  Burczynski ME, Peterson RL, Twine NC et al.: Molecular classification of Crohn’s disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J. Mol. Diagn.8,51–61 (2006).Crossref, Medline, CAS, Google Scholar
• 27  Knowlton N, Jiang K, Frank MB et al.: The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum.60,892–900 (2009).Crossref, Medline, CAS, Google Scholar
• 28  Griffin TA, Barnes MG, Ilowite NT et al.: Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum.60,2113–2123 (2009).Crossref, Medline, CAS, Google Scholar
• 29  Mesko B, Poliska S, Szegedi A et al.: Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med. Genomics3,15 (2010).Crossref, Medline, Google Scholar
• 30  Sinnaeve PR, Donahue MP, Grass P et al.: Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS ONE4,e7037 (2009).Crossref, Medline, Google Scholar
• 31  Wingrove JA, Daniels SE, Sehnert AJ et al.: Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ. Cardiovasc. Genet.1,31–38 (2008).Crossref, Medline, CAS, Google Scholar
• 32  Camargo A, Ruano J, Fernandez JM et al.: Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics11,253 (2010).Crossref, Medline, Google Scholar
• 33  Hermsdorff HH, Zulet MA, Puchau B, Martinez JA: Fruit and vegetable consumption and proinflammatory gene expression from peripheral blood mononuclear cells in young adults: a translational study. Nutr. Metab. (Lond.)7,42 (2010).Crossref, Google Scholar
• 34  Radom-Aizik S, Zaldivar F Jr, Leu SY, Galassetti P, Cooper DM: Effects of 30 min of aerobic exercise on gene expression in human neutrophils. J. Appl. Physiol.104,236–243 (2008).Crossref, Medline, CAS, Google Scholar
• 35  Radom-Aizik S, Zaldivar F Jr, Leu SY, Cooper DM: Brief bout of exercise alters gene expression in peripheral blood mononuclear cells of early- and late-pubertal males. Pediatr. Res.65,447–452 (2009).Crossref, Medline, CAS, Google Scholar
• 36  Radom-Aizik S, Zaldivar F Jr, Leu SY, Cooper DM: A brief bout of exercise alters gene expression and distinct gene pathways in peripheral blood mononuclear cells of early- and late-pubertal females. J. Appl. Physiol.107,168–175 (2009).Crossref, Medline, CAS, Google Scholar
• 37  Hayashi Y, Kajimoto K, Iida S et al.: DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting Type 2 diabetes. Biol. Pharm. Bull.33,1033–1042 (2010).Crossref, Medline, CAS, Google Scholar
• 38  Takamura T, Honda M, Sakai Y et al.: Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of Type 2 diabetes. Biochem. Biophys. Res. Commun.361,379–384 (2007).Crossref, Medline, CAS, Google Scholar
• 39  Huang H, Dong X, Kang MX et al.: Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. Am. J. Gastroenterol.105,1661–1669 (2010).Crossref, Medline, CAS, Google Scholar
• 40  Bushel PR, Heinloth AN, Li J et al.: Blood gene expression signatures predict exposure levels. Proc. Natl Acad. Sci. USA104,18211–18216 (2007).▪▪ Exciting work describing the ability of pharmacogenomic biomarkers to surpass classical toxicity measurements in rats and to impact the clinic.Crossref, Medline, CAS, Google Scholar
• 41  Lobenhofer EK, Auman JT, Blackshear PE et al.: Gene expression response in target organ and whole blood varies as a function of target organ injury phenotype. Genome Biol.9,R100 (2008).Crossref, Medline, Google Scholar
• 42  Huang J, Shi W, Zhang J et al.: Genomic indicators in the blood predict drug-induced liver injury. Pharmacogenomics J.10,267–277 (2010).Crossref, Medline, CAS, Google Scholar
• 43  Wetmore BA, Brees DJ, Singh R et al.: Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology51,2127–2139 (2010).Crossref, Medline, CAS, Google Scholar
• 44  O’Toole M, Janszen DB, Slonim DK et al.: Risk factors associated with β-amyloid(1–42) immunotherapy in preimmunization gene expression patterns of blood cells. Arch. Neurol.62,1531–1536 (2005).▪ Interesting paper describing biomarkers that can identify pre-exposure individuals who will develop adverse events.Crossref, Medline, Google Scholar
• 45  Yun JW, Lee TR, Kim CW et al.: Predose blood gene expression profiles might identify the individuals susceptible to carbon tetrachloride-induced hepatotoxicity. Toxicol. Sci.115,12–21 (2010).Crossref, Medline, CAS, Google Scholar
• 46  Yun JW, Kim CW, Bae IH et al.: Determination of the key innate genes related to individual variation in carbon tetrachloride-induced hepatotoxicity using a pre-biopsy procedure. Toxicol. Appl. Pharmacol.239,55–63 (2009).Crossref, Medline, CAS, Google Scholar
• 47  Thum T, Catalucci D, Bauersachs J: MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc. Res.79,562–570 (2008).Crossref, Medline, CAS, Google Scholar
• 48  Cortez MA, Calin GA: MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther.9,703–711 (2009).Crossref, Medline, CAS, Google Scholar
• 49  van Rooij E, Quiat D, Johnson BA et al.: A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell17,662–673 (2009).Crossref, Medline, CAS, Google Scholar
• 50  Fichtlscherer S, De RS, Fox H et al.: Circulating microRNAs in patients with coronary artery disease. Circ. Res.107,677–684 (2010).Crossref, Medline, CAS, Google Scholar
• 51  Liang M, Liu Y, Mladinov D et al.: MicroRNA: a new frontier in kidney and blood pressure research. Am. J. Physiol. Renal Physiol.297,F553–F558 (2009).Crossref, Medline, CAS, Google Scholar
• 52  Ryan BM, Robles AI, Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer10,389–402 (2010).Crossref, Medline, CAS, Google Scholar
• 53  Linsen SE, de Wit E, de Bruijn E, Cuppen E: Small RNA expression and strain specificity in the rat. BMC Genomics11,249 (2010).Crossref, Medline, Google Scholar
• 54  Olena AF, Patton JG: Genomic organization of microRNAs. J. Cell. Physiol.222,540–545 (2010).Medline, CAS, Google Scholar
• 55  Wittmann J , Jack HM: Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta1806(2),200–207 (2010).▪▪ Good review of miRNAs as biomarkers of cancer.Medline, CAS, Google Scholar
• 56  Liu DZ, Tian Y, Ander BP et al.: Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab.30,92–101 (2010).Crossref, Medline, Google Scholar
• 57  Cox MB, Cairns MJ, Gandhi KS et al.: MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS ONE5,e12132 (2010).Crossref, Medline, Google Scholar
• 58  Wang K, Zhang S, Marzolf B et al.: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl Acad. Sci. USA106,4402–4407 (2009).Crossref, Medline, CAS, Google Scholar
• 59  Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N: Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem.55,1944–1949 (2009).Crossref, Medline, CAS, Google Scholar
• 60  van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN: Control of stress-dependent cardiac growth and gene expression by a microRNA. Science316,575–579 (2007).Crossref, Medline, CAS, Google Scholar
• 61  Callis TE, Pandya K, Seok HY et al.: MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest.119,2772–2786 (2009).Crossref, Medline, CAS, Google Scholar
• 62  Wang GK, Zhu JQ, Zhang JT et al.: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J.31,659–666 (2010).Crossref, Medline, Google Scholar
• 63  Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M: Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J. Card. Fail.16,404–410 (2010).Crossref, Medline, CAS, Google Scholar
• 64  Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM: Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J. Appl. Physiol.109,252–261 (2010).Crossref, Medline, CAS, Google Scholar
• 65  Michiels S, Koscielny S, Hill C: Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet365,488–492 (2005).Crossref, Medline, CAS, Google Scholar
• 66  Ioannidis JP: Microarrays and molecular research: noise discovery? Lancet365,454–455 (2005).Crossref, Medline, Google Scholar
• 67  Shi L, Campbell G, Jones WD et al.: The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol.28,827–838 (2010).▪▪ Excellent evaluation by the microarray quality control consortia of the current issues regarding identifying and statistically validating pharmacogenomic biomarkers.Crossref, Medline, CAS, Google Scholar
• 68  Shi W, Bessarabova M, Dosymbekov D et al.: Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes. Pharmacogenomics J.10,310–323 (2010).Crossref, Medline, CAS, Google Scholar
• 69  Parry RM, Jones W, Stokes TH et al.: k-nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. Pharmacogenomics J.10,292–309 (2010).Crossref, Medline, CAS, Google Scholar
• 70  Luo J, Schumacher M, Scherer A et al.: A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J.10,278–291 (2010).Crossref, Medline, CAS, Google Scholar
• 71  Oberthuer A, Juraeva D, Li L et al.: Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients. Pharmacogenomics J.10,258–266 (2010).Crossref, Medline, CAS, Google Scholar
• 72  Fan X, Lobenhofer EK, Chen M et al.: Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J.10,247–257 (2010).Crossref, Medline, CAS, Google Scholar
• 73  Miclaus K, Chierici M, Lambert C et al.: Variability in GWAS analysis: the impact of genotype calling algorithm inconsistencies. Pharmacogenomics J.10,324–335 (2010).Crossref, Medline, CAS, Google Scholar
• 74  Miclaus K, Wolfinger R, Vega S et al.: Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K array. Pharmacogenomics J.10,336–346 (2010).Crossref, Medline, CAS, Google Scholar
• 75  Zhang L, Yin S, Miclaus K et al.: Assessment of variability in GWAS with CRLMM genotyping algorithm on WTCCC coronary artery disease. Pharmacogenomics J.10,347–354 (2010).Crossref, Medline, CAS, Google Scholar
• 76  Hong H, Shi L, Su Z et al.: Assessing sources of inconsistencies in genotypes and their effects on genome-wide association studies with HapMap samples. Pharmacogenomics J.10,364–374 (2010).Crossref, Medline, CAS, Google Scholar
• 77  Chierici M, Miclaus K, Vega S, Furlanello C: An interactive effect of batch size and composition contributes to discordant results in GWAS with the CHIAMO genotyping algorithm. Pharmacogenomics J.10,355–363 (2010).Crossref, Medline, CAS, Google Scholar
• 78  Fannin RD, Russo M, O’Connell TM et al.: Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology51,227–236 (2010).Crossref, Medline, CAS, Google Scholar
• 79  Stamova BS, Apperson M, Walker WL et al.: Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med. Genomics2,49 (2009).Crossref, Medline, Google Scholar
• 80  Walker WL, Liao IH, Gilbert DL et al.: Empirical Bayes accomodation of batch-effects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients. BMC Genomics9,494 (2008).Crossref, Medline, Google Scholar
• 81  Tillinghast GW: Microarrays in the clinic. Nat. Biotechnol.28,810–812 (2010).Crossref, Medline, CAS, Google Scholar
• 82  Baggerly KA, Coombes KR: Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann. Appl. Stat.3,1309–1334 (2009).▪▪ Important work that noted the problems with data that was being used to determine clinical treatments options.Crossref, Google Scholar
• 83  Goodsaid F, Papaluca M: Evolution of biomarker qualification at the health authorities. Nat. Biotechnol.28,441–443 (2010).Crossref, Medline, CAS, Google Scholar
• 84  Goodsaid FM, Mendrick DL: Translational medicine and the value of biomarker qualification. Sci. Transl. Med.2(47),ps44 (2010).Crossref, Google Scholar
• 85  Dieterle F, Sistare F, Goodsaid F et al.: Renal biomarker qualification submission: a dialog between the FDA–EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol.28,455–462 (2010).Crossref, Medline, CAS, Google Scholar
• 86  Mendrick DL: Genomic and genetic biomarkers of toxicity. Toxicology245,175–181 (2008).Crossref, Medline, CAS, Google Scholar
• 87  Mattes WB: Public consortium efforts in toxicogenomics. In: Essential Concepts in Toxicogenomics. Mendrick DL, Mattes WB (Eds.). Humana, NJ, USA 221–238 (2008).Google Scholar
• 101  US FDA: MicroArray Quality Control www.fda.gov/ScienceResearch/BioinformaticsTools/MicroarrayQualityControlProject/default.htmGoogle Scholar
• 102  FDA: Guidance for Industry: Qualification Process for Drug Development Tools. Draft Guidance (2010) www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM230597.pdfGoogle Scholar
• 103  Center for Disease Control and Prevention Public Health Image Library http://phil.cdc.gov/phil/home.aspGoogle Scholar
• 104  Professional Royalty-Free Stock Photos www.photos.comGoogle Scholar